Kim et al. investigated the relation of MUC5AC to serrated pathway-associated colorectal cancer and observed a 61% positive rate of MUC5AC expression in colorectal polyps and SSA/Ps and a significant association with sporadic tumors in MSI/H CRC cases [106]. The gene discussed is MUC5AC; the disease is colorectal cancer.